Piero Fracasso

Papers

2

Total Citations

59

H-Index

2

About

Piero Fracasso is a pioneering surgeon and researcher at the forefront of robotic-assisted urologic surgery, specializing in the comparative evaluation of next-generation surgical platforms. His major contributions center on the rigorous, prospective assessment of the Hugo RAS system versus the established da Vinci Xi, particularly during radical prostatectomy. Through the landmark COMPAR-P trial, Fracasso has provided the field with granular, real-world data on intraoperative performance, including timing, system malfunctions, and user satisfaction, as well as postoperative outcomes, pathological findings, and patient health-related quality of life. His work, published in 2024, has already garnered significant attention—with 36 and 23 citations respectively—underscoring its immediate impact on surgical practice. By systematically benchmarking emerging robotic technologies, Fracasso is helping to define evidence-based standards for surgical robotics, guiding hospitals and surgeons in technology adoption. His research is essential reading for anyone interested in the future of minimally invasive surgery, offering a transparent look at how new robotic systems perform in high-stakes, real-world settings.

Research Focus

Key Achievements

2
H-Index
2
Papers
59
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Intraoperative Performance of DaVinci Versus Hugo RAS During Radical Prostatectomy: Focus on Timing, Malfunctioning, Complications, and User Satisfaction in 100 Consecutive Cases (the COMPAR-P Trial)
36 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 28

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago